This inventor holds 16 USPTO granted patents, plus 1 CIPO patent, primarily in Antibiotic Compounds. Top assignees: Zeneca Limited, Astrazeneca Ab, Astra Zeneca U.k. Limited. Active years: 1995-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cheshire, GB (1997)
- Macclesfield, GB (2000 - 2006)
- Wilmslow, GB (1995 - 2008)
Company Filing History:
10 out of 854 
3 out of 1,534 
2 out of 110 
Years Active: 1995-2008
Areas of Expertise:
Title: The Innovative Journey of Michael John Betts
Introduction
Michael John Betts, an accomplished inventor based in Wilmslow, GB, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 16 patents, Betts is recognized for his innovations in antibiotic compounds and their derivatives. His work has had a notable impact on medical science, particularly in the development of novel antibiotic therapies.
Latest Patents
Among his latest patents, Betts has developed several crucial antibiotic compounds. One such patent focuses on carbapenems, providing a compound of a specific formula, or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof. Another recent patent highlights oxazolidinone derivatives with antibiotic activity, which also encompasses compounds of a particular formula, alongside their pharmaceutically acceptable salts or in-vivo hydrolysable esters. These innovations showcase Betts' commitment to addressing pressing health concerns through advanced chemical research.
Career Highlights
Michael John Betts has built his career through notable tenures at prestigious organizations. He has worked with Zeneca Limited and AstraZeneca AB, where he honed his expertise in pharmaceutical development. His experiences at these companies have played a pivotal role in his innovation journey, facilitating his growth as a leading inventor in his field.
Collaborations
Throughout his career, Betts has collaborated with several accomplished colleagues, including Gareth Morse Davies and Michael Lingard Swain. Their combined expertise has fostered an environment of creativity and innovation, resulting in groundbreaking advancements in antibiotic research.
Conclusion
Michael John Betts stands out as a distinguished inventor dedicated to the field of pharmaceuticals. His extensive portfolio of patents, innovative approach to antibiotic compounds, and collaborative spirit have solidified his reputation as a key player in medical innovation. Betts’ work continues to inspire new avenues for research and development in the fight against bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile